|
|
|
|
|
|
|
|
|
|
UW Medicine Online News
"Because UW-OncoPlex is primarily a clinical tool, the focus is on actionable driver mutations. As a result, the UW-OncoPlex panel studies genes with mutations known to cause cancer variants for which a highly effective therapies are currently available. As of January 2013, the UW-OncoPlex panel includes 194 genes. This number will increase on a rolling basis, as the system easily scales up to accommodate new targets."
"Diseases targeted and treated with UW-OncoPlex at SCCA currently include:
Melanoma
Lung cancer
Leukemia
Sarcoma"
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.